Perceived stigma among patients receiving antiretroviral treatment: A prospective randomised trial comparing an m-DOT strategy with standard-of-care in Kenya
Document Type
Article (peer-reviewed)
Publication Date
2010
Abstract
HIV and AIDS remain highly stigmatised. Modified directly observed therapy (m-DOT) supports antiretroviral treatment (ART) adherence but little is known about its association with perceived stigma in resource-constrained settings. In 2003, 234 HIV-infected adults enrolled in a two-arm randomised trial comparing a health centre-based m-DOT strategy with standard self-administration of ART. Data on perceived stigma were collected using Berger's HIV stigma scale prior to starting ART and after 12 months. This was a secondary analysis to examine whether perceived stigma was related to treatment delivery. Perceived stigma scores declined after 12 months of treatment from a mean of 44.9 (sd=7.6) to a mean of 41.4 (sd=7.7), (t=6.14, P
Recommended Citation
Kaai, Susan, Sandra Bullock, Avina Sarna, Matthew F. Chersich, Stanley Luchters, Scott Geibel, Paul Munyao, Kishorchandra N. Mandaliya, Marleen Temmerman, and Naomi Rutenberg. 2010. "Perceived stigma among patients receiving antiretroviral treatment: A prospective randomised trial comparing an m-DOT strategy with standard-of-care in Kenya," Journal of Social Aspects of HIV/AIDS 7(2): 62–70.
DOI
10.1080/17290376.2010.9724958
Language
English
